EtiraRX, Inc. — Form D
EtiraRX, Inc. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-05. The offering totals $10.6M, of which $4.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-10-05
- Form: D
- Accession: 0001996442-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.6M
- Amount sold: $4.8M
- Remaining: $5.8M
- Investors: 34
- Date of first sale: 2023-09-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-493949
Issuer
- Name: EtiraRX, Inc.
- CIK: 0001996442
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 3060 PEGASUS PARK DRIVE BUILDING 6, DALLAS, TX, 75247
- Phone: 469-600-6603
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Ganesh Raj | Executive Officer | Dallas, TX |
| Ganesh Raj | Director | Dallas, TX |
| Ganesh Raj | Related Person | Dallas, TX |
| Annalisa Jenkins | Director | Dallas, TX |
| Annalisa Jenkins | Related Person | Dallas, TX |
| Russell Hayward | Director | Dallas, TX |
| Russell Hayward | Executive Officer | Dallas, TX |
| Russell Hayward | Related Person | Dallas, TX |
| Justin Stebbing | Related Person | Dallas, TX |
Other filings by this issuer (2)
More